Early research (Phase 1)Study completedNCT02639260
What this trial is testing
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Who this might be right for
Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10